Age-related macular degeneration and mortality from cardiovascular disease or stroke

British Journal of Ophthalmology

Volumn 92, Issue 4, 2008, Pages 509-512

  Tan, J S L ^a   Wang, J J ^a   Liew, G ^a   Rochtchina, E ^a   Mitchell, P ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONFIDENCE INTERVAL; DEATH; EYE PHOTOGRAPHY; FEMALE; HISTORY; HUMAN; MALE; MORTALITY; PHYSICAL EXAMINATION; POPULATION; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RATING SCALE; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SEX; STROKE; UNITED STATES;

AGE FACTORS; AGED; AUSTRALIA; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROGNOSIS; STROKE;

EID: 41849120485     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.131706     Document Type: Article

References (22)

1. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007;369:425-35.
2. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 1999;6:125-43.
3. Wong TY, Tikellis G, Sun C, et al. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Ophthalmology 2007;114:86-91.
4. Wong TY, Klein R, Sun C, et al. Age-related macular degeneration and risk for stroke. Ann Intern Med 2006;145:98-106.
5. Duan Y, Mo J, Klein R, et al. Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology 2007;114:732-7.
6. Buch H, Vinding T, la Cour M, et al. Age-related maculopathy: a risk indicator for poorer survival in women: the Copenhagen City Eye Study. Ophthalmology 2005;112:305-12.
7. Liew G, Mitchell P. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2007;356:747-8.
8. Genentech. Lucentis (ranibizumab injection) safety information letter. http:// www.fda.gov/medwatch/safety/2007/Lucentis_DHCP_01-24-2007.pdf (accessed 16 Sep 2007).
9. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
10. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-34.
11. Whitworth JA; World Health Organization/International Society of Hypertension Writing Group. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
12. Magliano D, Liew D, Pater H, et al. Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. Aust N Z J Public Health 2003;27:649-53.
13. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003;110:25-33.
14. Goldberg J, Flowerdew G, Smith E, et al. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Survey. Am J Epidemiol 1988;128:700- 10.
15. Walker AH, Restuccia JD. Obtaining information on patient satisfaction with hospital care: mail versus telephone. Health Serv Res 1984;19:291-306.
16. Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280-7.
17. Tan JS, Mitchell P, Smith W, et al. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration. The Blue Mountains Eye Study. Ophthalmology 2007;114:1143-50.
18. Thiagarajan M, Evans JR, Smeeth L, et al. Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. Arch Ophthalmol 2005;123:1397-403.
19. Donoso LA, Kim D, Frost A, et al. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006;51:137-52.
20. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-8.
21. Kuehn BM. Gene discovery provides clues to cause of age-related macular degeneration. JAMA 2005;293:1841-5.
22. Di Napoli M. Systemic complement activation in ischemic stroke. Stroke 2001;32:1443-8.